Filing Details
- Accession Number:
- 0001209191-20-008293
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 16:16:38
- Reporting Period:
- 2020-02-07
- Accepted Time:
- 2020-02-11 16:16:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1780556 | David Jakeman | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham NC 27713 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-02-07 | 2,290 | $1.70 | 87,876 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares were sold in payment of the reporting person's tax liability incurred upon the vesting of shares subject to restricted stock unit awards granted on January 24, 2017, January 25, 2018 and January 23, 2019.